StockClub

ATRA

ATRAAtara Biotherapeutics, Inc.$ --
Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

ATRA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
2M USD
YoY -95.1%
Operating Income
-3M USD
YoY +78.8%
Net Income
-3M USD
YoY +73.2%
EPS
-0.25$
YoY +79.0%

Revenue

$120.8M
FY2024 Q1$27.4M
$27.4M
Q1
FY2024 Q2$56M
$56M
Q2
FY2024 Q3$96.2M
$96.2M
Q3
FY2024 Q4$128.9M
$128.9M
Q4
FY2025 Q1$98.1M
$98.1M
Q1
FY2025 Q2$115.7M
$115.7M
Q2
FY2025 Q3$119.2M
$119.2M
Q3
FY2025 Q4$120.8M
$120.8M
Q4
Actual
$-8.2M (-6.3%)

Net Income

$32.7M
FY2024 Q1$-31.8M
$-31.8M
Q1
FY2024 Q2$-50.8M
$-50.8M
Q2
FY2024 Q3$-72.7M
$-72.7M
Q3
FY2024 Q4$-85.4M
$-85.4M
Q4
FY2025 Q1$38M
$38M
Q1
FY2025 Q2$40.4M
$40.4M
Q2
FY2025 Q3$36.1M
$36.1M
Q3
FY2025 Q4$32.7M
$32.7M
Q4
Actual
+$118.1M (+138.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$0
Est:$15M
FY2020MISS
$0
FY2021MISS
Actual:$20.3M
Est:$41.6M
FY2021MISS
$20.3M
FY2022MISS
Actual:$63.6M
Est:$96.8M
FY2022MISS
$63.6M
FY2023MISS
Actual:$8.6M
Est:$34.7M
FY2023MISS
$8.6M
FY2024BEAT
Actual:$128.9M
Est:$116.6M
FY2024BEAT
$128.9M
FY2025MISS
Actual:$120.8M
Est:$121.7M
FY2025MISS
$120.8M

Analyst Estimates